Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

Leonieke J. J. van Mens; Marleen G. H. van de Sande; Arno W. R. van Kuijk; Dominique Baeten; Laura C. Coates

doi:https://doi.org/10.1136/annrheumdis-2019-215990

Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

Leonieke J. J. van Mens, Marleen G. H. van de Sande, Arno W. R. van Kuijk, Dominique Baeten, Laura C. Coates

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	e143
Pages (from-to)	e143
Journal	Annals of the rheumatic diseases
Volume	79
Issue number	11
DOIs	https://doi.org/10.1136/annrheumdis-2019-215990
Publication status	Published - 1 Nov 2020

Keywords

arthritis
psoriatic arthritis

Access to Document

https://doi.org/10.1136/annrheumdis-2019-215990

Cite this

@article{5c4f861151324feba99b5122d4e23103,

title = "Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gon{\c c}alves et al",

keywords = "arthritis, psoriatic arthritis",

author = "{van Mens}, {Leonieke J. J.} and {van de Sande}, {Marleen G. H.} and {van Kuijk}, {Arno W. R.} and Dominique Baeten and Coates, {Laura C.}",

year = "2020",

month = nov,

day = "1",

doi = "https://doi.org/10.1136/annrheumdis-2019-215990",

language = "English",

volume = "79",

pages = "e143",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "11",

}

Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al. / van Mens, Leonieke J. J.; van de Sande, Marleen G. H.; van Kuijk, Arno W. R. et al.
In: Annals of the rheumatic diseases, Vol. 79, No. 11, e143, 01.11.2020, p. e143.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

AU - van Mens, Leonieke J. J.

AU - van de Sande, Marleen G. H.

AU - van Kuijk, Arno W. R.

AU - Baeten, Dominique

AU - Coates, Laura C.

PY - 2020/11/1

Y1 - 2020/11/1

KW - arthritis

KW - psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=85092943886&partnerID=8YFLogxK

U2 - https://doi.org/10.1136/annrheumdis-2019-215990

DO - https://doi.org/10.1136/annrheumdis-2019-215990

M3 - Article

C2 - 31331923

SN - 0003-4967

VL - 79

SP - e143

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 11

M1 - e143

ER -

Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

Keywords

Access to Document

Other files and links

Cite this